血液基因表达与免疫细胞亚型与慢阻肺急性加重相关
研究基于COPDGene队列的血液RNA测序数据(n=3,618)分析基因表达与急性加重关联,并在ECLIPSE队列(n=646)微阵列数据中验证;SPIROMICS队列(n=127)流式细胞术检测T细胞活化标志物。发现890、675、3,217个基因分别与既往加重史、持续性加重及前瞻性加重率相关,循环淋巴细胞(尤其CD4+ T细胞)降低者更易发生急性加重。
要点
- 循环CD8+ T细胞、CD4+ T细胞及静息NK细胞数量与前瞻性加重次数呈负相关。
- 初始CD4+ T细胞降低与急性加重的负相关在ECLIPSE队列中得到重复验证。
- CD4+ T细胞上CTLA4升高与急性加重呈正相关。
核心结论
- COPD患者循环淋巴细胞计数降低,尤其CD4+ T细胞减少,与急性加重易感性增加相关,包括持续性加重。
研究设计与样本
- COPDGene队列血液RNA测序数据(n=3,618)分析基因表达与急性加重关联;ECLIPSE队列血液微阵列数据(n=646)用于验证;SPIROMICS队列(n=127)流式细胞术检测T细胞活化标志物。
主要发现
- COPDGene随访(5.3±1.7年)报告急性加重4,030次,ECLIPSE随访3年报告2,368次。
- 鉴定出890、675、3,217个基因分别与既往加重史、持续性加重(每年至少一次加重)及前瞻性加重率相关。
- COPDGene中GOLD分期≥2的COPD患者前瞻性加重次数与循环CD8+ T细胞、CD4+ T细胞及静息NK细胞呈负相关。
- 初始CD4+ T细胞的负相关在ECLIPSE中重复验证;流式细胞术中CD4+ T细胞CTLA4升高与急性加重正相关。
关键数值与推荐
- COPDGene随访5.3±1.7年报告急性加重4,030次,ECLIPSE随访3年报告2,368次。
- 890个基因与既往加重史相关,675个与持续性加重相关,3,217个与前瞻性加重率相关。
- 流式细胞术样本n=127;ECLIPSE验证样本n=646;COPDGene分析样本n=3,618。
临床怎么用
- 血免疫表型(尤其CD4+ T细胞计数及CTLA4表达)可能有助于识别急性加重高风险COPD患者。
- 对循环淋巴细胞降低的COPD患者可加强加重预防与随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AE-COPDs) are associated with a significant disease burden. Blood immune phenotyping may improve our understanding of a COPD endotype at increased risk of exacerbations. Objective: To determine the relationship between the transcriptome of circulating leukocytes and COPD exacerbations. Methods: Blood RNA sequencing data (n = 3,618) from the COPDGene (Genetic Epidemiology of COPD) study were analyzed. Blood microarray data (n = 646) from the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) study were used for validation. We tested the association between blood gene expression and AE-COPDs. We imputed the abundance of leukocyte subtypes and tested their association with prospective AE-COPDs. Flow cytometry was performed on blood in SPIROMICS (Subpopulations and Intermediate Outcomes in COPD Study) (n = 127), and activation markers for T cells were tested for association with prospective AE-COPDs. Measurements and Main Results: Exacerbations were reported 4,030 and 2,368 times during follow-up in COPDGene (5.3 ± 1.7 yr) and ECLIPSE (3 yr), respectively. We identified 890, 675, and 3,217 genes associated with a history of AE-COPDs, persistent exacerbations (at least one exacerbation per year), and prospective exacerbation rate, respectively. In COPDGene, the number of prospective exacerbations in patients with COPD (Global Initiative for Chronic Obstructive Lung Disease stage ⩾2) was negatively associated with circulating CD8+ T cells, CD4+ T cells, and resting natural killer cells. The negative association with naive CD4+ T cells was replicated in ECLIPSE. In the flow-cytometry study, an increase in CTLA4 on CD4+ T cells was positively associated with AE-COPDs. Conclusions: Individuals with COPD with lower circulating lymphocyte counts, particularly decreased CD4+ T cells, are more susceptible to AE-COPDs, including persistent exacerbations.
引用
- Ryu, Yun, Morrow, et al. Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations. Am J Respir Crit Care Med. 2023. PMID: 37286295. doi:10.1164/rccm.202301-0085OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。